ArticleHuman cell2022
Pan-cancer analysis reveals homologous recombination deficiency score as a predictive marker for immunotherapy responders.
Can Yang et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
24 papers cite it
this papertrialcites it